🇰🇷 South Korea Country × Condition
epidermal growth factor receptor Clinical Trials in South Korea
Active clinical trials for epidermal growth factor receptor with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT07462377 Phase 1
Recruiting
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Enrollment
110 pts
Country
🇰🇷 South Korea
EpiBiologics
View Trial → NCT07073365 Phase 2
Recruiting
Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial)
Enrollment
70 pts
Country
🇰🇷 South Korea
Pusan National University Hospital
View Trial → Frequently Asked Questions
How many epidermal growth factor receptor clinical trials are active in South Korea?
There are currently 2 active clinical trials for epidermal growth factor receptor with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a epidermal growth factor receptor clinical trial in South Korea?
To join a epidermal growth factor receptor clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are epidermal growth factor receptor trials in South Korea?
Active epidermal growth factor receptor trials in South Korea span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology